Replimune Group, Inc. Gains 35.11%
Fri, Nov 22, 2024 at 07:25 PM
Replimune Group, Inc. (REPL:NASDAQ) jumped higher at $14.93, representing a gain of 35.1%. On Fri, Nov 22, 2024, REPL:NASDAQ hit a New 2-Week High of $14.93. The stock got featured on our News Catalysts scanner on Fri, Nov 22, 2024 at 06:35 AM in the 'BIOTECH' category. From Fri, Nov 08, 2024, the stock recorded 40.00% Up Days and 45.45% Green Days
About Replimune Group, Inc. (REPL:NASDAQ)
Replimune Group Inc is a clinical-stage biotechnology company. Its use proprietary Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The company's pipeline products include RP1, RP2, and RP3.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 243.14%
- Palladyne AI Corp. (PDYN:NASDAQ), 130%
- Nano Labs Ltd (NA:NASDAQ), 89.02%
- SKK Holdings Limited (SKK:NASDAQ), 67.27%
- Wellchange Holdings Company Limited (WCT:NASDAQ), 58.4%
- D-Wave Quantum Inc. (QBTS:NYSE), 48.73%
- Omeros Corporation (OMER:NASDAQ), 41.14%
- Replimune Group, Inc. (REPL:NASDAQ), 35.11%
- Quantum-Si Incorporated (QSI:NASDAQ), 33.88%
- Agrify Corporation (AGFY:NASDAQ), 32.35%